임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 3상모집 중· Moderately to Severely Active Crohns DiseaseA Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease
리드: 로슈
- 3상모집 중· Moderately to Severely Active Ulcerative ColitisA Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
리드: 로슈
- 3상모집 예정· Hepatocellular Carcinoma (HCC)A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic Therapy
협력: 로슈
- 3상모집 중· Neovascular Age-related Macular DegenerationA Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
리드: 로슈
- 3상모집 중· Alzheimers DiseaseA Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
리드: 로슈
- 3상모집 중· Non-Small Cell Lung CancerA Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
리드: 로슈
- 3상모집 중· High Risk Cardiovascular DiseaseZilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
협력: 로슈
- 3상모집 중· Alzheimers DiseaseA Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
리드: 로슈
- 3상모집 중· Proliferative Diabetic Retinopathy (PDR)Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
협력: 로슈
- 3상모집 중· Alzheimers DiseaseScreening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
리드: 로슈
- 3상모집 중· Von Willebrand Disease, Type 3A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease
리드: 로슈
- 3상모집 중· Moderately to Severely Active Crohns DiseaseA Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
리드: 로슈
- 3상모집 중· Moderately to Severely Active Crohns DiseaseA Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
리드: 로슈
- 3상모집 중· Moderately to Severely Active Ulcerative ColitisA Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
리드: 로슈
- 3상모집 중단 (진행 중)· Moderately to Severely Active Ulcerative ColitisA Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
리드: 로슈
- 3상모집 중· Neovascular Age-related Macular DegenerationA Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD)
리드: 로슈
- 3상모집 중· Estrogen Receptor-Positive, HER2-Negative Advanced Breast CancerA Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
리드: 로슈
- 3상모집 중단 (진행 중)· Thyroid Eye DiseaseA Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease
리드: 로슈
- 3상모집 중단 (진행 중)· Thyroid Eye DiseaseStudy to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease
리드: 로슈
- 3상초청 등록· Duchenne Muscular DystrophyA Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study
협력: 로슈
- 3상모집 중· Chronic Obstructive Pulmonary DiseaseA Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
리드: 로슈
- 3상모집 중단 (진행 중)· Breast CancerA Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
리드: 로슈
- 3상모집 중단 (진행 중)· Childhood Idiopathic Nephrotic SyndromeA Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome
리드: 로슈
- 3상모집 중단 (진행 중)· Chronic Obstructive Pulmonary Disease (COPD)A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
리드: 로슈
- 3상모집 중단 (진행 중)· Non-Small Cell Lung CancerA Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)
리드: 로슈
- 3상모집 중· Acute Myeloid LeukemiaVenetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
협력: 애브비, 로슈
- 3상모집 중단 (진행 중)· Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
리드: 로슈
- 3상모집 중단 (진행 중)· Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerA Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)
리드: 로슈
- 3상모집 중단 (진행 중)· Locally Advanced or Metastatic Breast CancerA Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)
리드: 로슈
- 3상모집 중단 (진행 중)· Non-Small Cell Lung CancerA Study of Atezolizumab in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer
리드: 로슈
- 3상모집 중단 (진행 중)· Relapsing-remitting Multiple SclerosisA Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)
리드: 로슈
- 3상모집 중단 (진행 중)· Multiple SclerosisA Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
리드: 로슈
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.